InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,484.52
(
0.12%
)
US TECH 100
19,293.20
(
0.41%
)
Dow Jones
39,121.90
(
-0.02%
)
Brent Oil
85.19
(
0.85%
)
Bitcoin
62,181.16
(
2.26%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: DonShimoda post# 8194

Thursday, 05/19/2011 8:30:28 AM

Thursday, May 19, 2011 8:30:28 AM

Post# of 80490

I found the endometrial results superior to those achieved in the everolimus trial



How is that?

The everolimus trial was talking about CR and PR (something the Ridaforolimus trial couldn't acheieve according to that abstract - the best result was stable disease).

When you're talking about COMPLETE responses, you start talking about real cures...not simply delaying the disease with a host of side effects to come with it.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up